News Features
PharmaCyte Biotech’s Pancreatic Cancer Therapy Passes Critical FDA-Required Tests as Countdown to IND Submission Begins
January 27, 2020 by in News Features
PharmaCyte Biotech’s Pancreatic Cancer Therapy Passes Critical FDA-Required Tests as Countdown to IND Submission Begins
More
Share
News Features
PharmaCyte Biotech Closer to Submitting IND with Successful Completion of Clinical Trial Product
October 16, 2019 by in News Features
PharmaCyte Biotech Closer to Submitting IND with Successful Completion of Clinical Trial Product
More
Share
News Features
PharmaCyte Biotech Nearing Major Milestone—An Open IND with the FDA
February 4, 2019 by in News Features
PharmaCyte Biotech Nearing Major Milestone—An Open IND with the FDA
More
Share
News Features
World-Renowned Oncologist Bullish on Potential of PharmaCyte’s Technology, Clinical Trial in Pancreatic Cancer
January 23, 2019 by in News Features
World-Renowned Oncologist Bullish on Potential of PharmaCyte’s Technology, Clinical Trial in Pancreatic Cancer
More
Share
News Features
PharmaCyte’s Clinical Trial in Pancreatic Cancer Serves as Proving Ground for Its One of a Kind Cell Encapsulation Technology
June 6, 2018 by in News Features
PharmaCyte’s Clinical Trial in Pancreatic Cancer Serves as Proving Ground for Its One of a Kind Cell Encapsulation Technology
More
Share